Tokyo Tape
Sign in
← Takara Holdings

Quarterly report · Q2

2531.TEDINET S100S6LP
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥163.2bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥350.7bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥164.3bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥12.5bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥19.6bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥13.0bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥38.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥20.0bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥13.0bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥20.8bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥8.0bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥21.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥9.0bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥14.8bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥420.9bnat 2023-09-30Cons.Assets
Total assets¥399.2bnat 2023-03-31Cons.Assets
Total assets¥366.3bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥148.8bnat 2023-09-30Cons.Liabilities
Total liabilities¥143.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥272.1bnat 2023-09-30Cons.Net assets
Net assets / equity¥255.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥244.3bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥89.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥96.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥84.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥91.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥56.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥75.7bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥14.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥45.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥7.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥15.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥9.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥22.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥21.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥40.692023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.572023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥107.262022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥552022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.482022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio52.2%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio51.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio53.3%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥14.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥6.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥8.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥9.2bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥9.2bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥348m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2023-04-01 → 2023-09-30¥77.2bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2023-04-01 → 2023-09-30¥76.9bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥282m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.3bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2023-04-01 → 2023-09-30¥19.1bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2023-04-01 → 2023-09-30¥19.1bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥0
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.4bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2023-04-01 → 2023-09-30¥61.2bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2023-04-01 → 2023-09-30¥60.7bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥486m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2023-04-01 → 2023-09-30¥4.0bn
—segment totalrevenue2023-04-01 → 2023-09-30¥157.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥156.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥768m
—segment totalsegment profit2023-04-01 → 2023-09-30¥11.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥172.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥163.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥9.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥12.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥15.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥6.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥8.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥9.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥9.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥216m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2022-04-01 → 2022-09-30¥63.7bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2022-04-01 → 2022-09-30¥63.6bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥121m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.7bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2022-04-01 → 2022-09-30¥32.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2022-04-01 → 2022-09-30¥32.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥2m
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2022-04-01 → 2022-09-30¥10.9bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2022-04-01 → 2022-09-30¥61.8bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2022-04-01 → 2022-09-30¥61.3bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥483m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥158.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥157.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥608m
—segment totalsegment profit2022-04-01 → 2022-09-30¥18.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥173.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥164.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥9.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥19.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 519
ItemContextValueUnit
Equity in losses of affiliates noePrior1YTDDuration113000000JPY
Equity in losses of affiliates noeCurrentYTDDuration－JPY
Foreign exchange losses noePrior1YTDDuration113000000JPY
Foreign exchange losses noeCurrentYTDDuration－JPY
Provision for loss on litigation noePrior1YTDDuration－JPY
Provision for loss on litigation noeCurrentYTDDuration109000000JPY
Other noePrior1YTDDuration163000000JPY
Other noeCurrentYTDDuration185000000JPY
Non operating expensesPrior1YTDDuration539000000JPY
Non operating expensesCurrentYTDDuration480000000JPY
Ordinary incomePrior1YTDDuration19972000000JPY
Ordinary incomeCurrentYTDDuration13032000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration252000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration28000000JPY
Gain on sales of investment securities eiPrior1YTDDuration－JPY
Gain on sales of investment securities eiCurrentYTDDuration8000000JPY
Insurance income eiPrior1YTDDuration652000000JPY
Insurance income eiCurrentYTDDuration－JPY
State subsidy eiPrior1YTDDuration63000000JPY
State subsidy eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration967000000JPY
Extraordinary incomeCurrentYTDDuration36000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration45000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration84000000JPY
Loss on reduction of noncurrent assets elPrior1YTDDuration63000000JPY
Loss on reduction of noncurrent assets elCurrentYTDDuration－JPY
Other elPrior1YTDDuration16000000JPY
Other elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration125000000JPY
Extraordinary lossCurrentYTDDuration84000000JPY
Income before income taxesPrior1YTDDuration20815000000JPY
Income before income taxesCurrentYTDDuration12984000000JPY
Income taxes currentPrior1YTDDuration5405000000JPY
Income taxes currentCurrentYTDDuration4290000000JPY
Income taxes deferredPrior1YTDDuration580000000JPY
Income taxes deferredCurrentYTDDuration-337000000JPY
Income taxesPrior1YTDDuration5985000000JPY
Income taxesCurrentYTDDuration3953000000JPY
Profit lossPrior1YTDDuration14829000000JPY
Profit lossCurrentYTDDuration9031000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration3956000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration988000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration10873000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration8043000000JPY
Profit lossPrior1YTDDuration14829000000JPY
Profit lossCurrentYTDDuration9031000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-1113000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration4688000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration372000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration3000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass